Category: Pharmaceuticals
Global Pharmaceuticals
-
Orthopedic Prosthetic Implants
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.9 Billion by ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Clinical Trial Management Systems (CTMS)
... is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is expected to record a 15.0% ... Read More
-
Vertebral Compression Fracture Devices
... reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Prenatal Diagnostics
... at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Companion Diagnostics
... at a CAGR of 2.1% over the analysis period 2023-2030. Companion Diagnostics Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$9.7 Billion ... Read More
-
e-Clinical Trial Technologies
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
Diabetes Diagnostics
... at a CAGR of 8.6% over the analysis period 2023-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of ... Read More
-
Tuberculosis Testing
... at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Nanocatalysts
... of 7.5% over the analysis period 2023-2030. Refinery & Petrochemicals Application, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Ovulation Test
... at a CAGR of 4.0% over the analysis period 2023-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Global Gait Analyzer Market Research Report 2024
... during the forecast period 2024-2030. In 2023 the Global Gait Analyzer production were 1,057 Units and it will be 1,908 Units in 2030, with a CAGR of 8.62% between 2024 and 2030. Europe and North ... Read More
-
Radio Frequency Identification (RFID) Technology
... is expected to reach US$97.5 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.1% ... Read More
-
Contract Research Outsourcing
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$61.2 Billion ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... US$6.5 Billion in the year 2023, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic Braces & Supports, one of the segments analyzed in ... Read More
-
Herpes Simplex Virus Infections
... reach US$6.6 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes ... Read More
-
Automated Storage and Retrieval Systems (ASRS)
... the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Unit Load ASRS, one of the segments analyzed in the report, is expected ... Read More
-
Corporate Wellness
... at a CAGR of 6.6% over the analysis period 2023-2030. Small-scale Organizations End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$19.2 Billion by the end ... Read More
-
Interventional Radiology Systems
... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$12.7 Billion by ... Read More
-
Bulk Paclitaxel
... at a CAGR of 8.6% over the analysis period 2023-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$139.1 Million by the end ... Read More
Research Assistance
